Now showing items 1-1 of 1

    • Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research 

      Unknown author (‎2015)‎
      This report, with a focus on sustainable access to new medicines, reviews policies that affect medicines throughout their lifecycle (‎from research and development to disinvestment)‎, examining the current evidence base across Europe. While many European countries have not traditionally required active priority-setting for access to medicines, appraising new medicines using pharmacoeconomics is increasingly seen as critical in order to improve efficiency in spending while maintaining an appropriate balance between access and cost–effectiveness. ...